1
2
3

major breakthrough

After 10 years of hard work, the research and development team of Wuxi Beta Pharmaceutical Technology Co., Ltd. has conqueredCarbon -14 MarkDifficulties in key compound preparation and labeling techniques, and willCarbon -14 MarkIntegrated application of a number of modern advanced technology, successfully developed for the diagnosis of gastric Helicobacter pylori infection with the key shortage of raw materials such as urea-14C and urea-13C, to achieve real domestic alternative imports, to meet the domestic new medicine, new pesticides research and development needs.


"Since entering the Biomedical Industrial Park in Jiangyin High-tech Zone in November 2008, under the guidance of Zhou Yongmao, an academician of the Chinese Academy of Engineering and an expert in nuclear reactor engineering, and with the support of scientific and technological projects such as the Ministry of Science and Technology and Jiangsu Province, we have specialized in R & D and labeling services for isotope labeled compounds such as carbon -14 and carbon -13." Dr. Li Gang, winner of the second prize for national scientific and technological progress and a returned entrepreneur from the United States, said that the main direction of attack is to provide "high, precise and deficient" carbon -14, carbon -13 and other isotope labeling products and tracer technology services for the pharmaceutical, pesticide research and development industry and medical testing industry, so as to meet the urgent needs of China in the fields of drug generation, clinical, environmental research and disease detection.


Isotope labeling is an important aspect of the peaceful use of nuclear energy, and it is also an important part of the nuclear industry serving medicine, pesticides, environmental protection industries, the national economy and people's lives. For a long time, due to the blockade of foreign technology, China has been used for pharmaceutical, clinical and environmental research.Carbon -14 MarkThe vast majority need to be sent abroad to do, expensive, long cycle, communication is not convenient, become the bottleneck of development.


At present, Wuxi Beta's self-developed for pharmaceutical, clinical and environmental research.Carbon -14 Mark, has provided more than 10 successful marks of new drugs for Sichuan Kelun Pharmaceutical Research Institute, Jiangsu Hengrui Pharmaceutical (600276), Nanjing Shenghe Pharmaceutical and other advanced enterprises of pesticide research and development, which are more efficient, cheaper and more convenient to communicate than similar technical services abroad, realizing real domestic substitution and ending the history of sending them abroad for isotope marking, it can fully meet the research needs of new medicines and new pesticides in China, and its development prospects are very broad.